Policies and Guidelines
- Biologically Active Agents Used in CAM and Placebo Materials—Policy and Guidance
- Guidelines for NCCAM-supported Clinical Trials
- Applying for NCCAM Clinical Trials Grants: Points to Consider
- Considerations for NCCAM Clinical Trial Grant Applications
- Guidance on Designing Clinical Trials of CAM Therapies: Determining Dose Ranges
- NCCAM Terms of Awards for Clinical Trials
- Data and Safety Monitoring Guidelines for NCCAM-supported Clinical Trials
- Phase III Clinical Trials
- NIH Policy on Data and Safety Monitoring Boards (NIH)
- Adverse Events (NIH)
- Human Subjects and Animal Protection
- Certificates of Confidentiality (NIH)
- Office for Human Research Protections (HHS)
- Required Education in the Protection of Human Research Participants (NIH)
- FAQ on Required Education in the Protection of Human Research Participants (NIH)
- Human and Animal Subject Protection (PDF) (NIH)
- Office of Animal Care and Use (NIH)
- NIH Grants Policy Statement (NIH)
- Policy Notices (NIH)
Note: PDF files requires a viewer such as the free Adobe Reader.
